• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于重症监护药学服务的立场文件。危重病医学协会和美国临床药师协会。

Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy.

出版信息

Pharmacotherapy. 2000 Nov;20(11):1400-6.

PMID:11079290
Abstract

OBJECTIVE

To identify and describe the scope of practice that characterizes the critical care pharmacist and critical care pharmacy services. Specifically, the goals were to define the level of clinical practice and specialized skills characterizing the critical care pharmacist as clinician, educator, researcher, and manager; and to recommend fundamental, desirable, and optimal pharmacy services and personnel requirements for the provision of pharmaceutical care to critically ill patients. Hospitals having comprehensive resources as well as those with more limited resources were considered.

DATA SOURCES

Consensus of critical care pharmacists from institutions of various sizes providing critical care services within several types of pharmacy practice models was obtained, including community-based and academic practice settings. Existing guidelines and literature describing pharmacy practice and drug use processes were reviewed and adapted for the critical care setting.

CONCLUSIONS

By combining the strengths and expertise of critical care pharmacy specialists with existing supporting literature, these recommendations define the level of clinical practice and specialized skills that characterize the critical care pharmacist as clinician, educator, researcher, and administrator. This position paper recommends fundamental, desirable, and optimal pharmacy services as well as personnel requirements for the provision of pharmaceutical care to critically ill patients.

摘要

目的

识别并描述重症监护药师及重症监护药学服务的执业范围。具体而言,目标是界定作为临床医生、教育工作者、研究者和管理者的重症监护药师的临床实践水平和专业技能;并推荐为重症患者提供药学服务所需的基础、理想和最佳药学服务及人员要求。研究考虑了拥有全面资源的医院以及资源较为有限的医院。

数据来源

获取了来自不同规模机构、在多种药学实践模式(包括社区和学术实践环境)中提供重症监护服务的重症监护药师的共识。对描述药学实践和药物使用过程的现有指南及文献进行了审查,并针对重症监护环境进行了调整。

结论

通过将重症监护药学专家的优势和专业知识与现有支持性文献相结合,这些建议界定了作为临床医生、教育工作者、研究者和管理者的重症监护药师的临床实践水平和专业技能。本立场文件推荐了为重症患者提供药学服务所需的基础、理想和最佳药学服务以及人员要求。

相似文献

1
Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy.关于重症监护药学服务的立场文件。危重病医学协会和美国临床药师协会。
Pharmacotherapy. 2000 Nov;20(11):1400-6.
2
Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services.关于重症监护药学服务的立场文件。危重病医学会和美国临床药学院重症监护药学服务特别工作组。
Crit Care Med. 2000 Nov;28(11):3746-50. doi: 10.1097/00003246-200011000-00037.
3
Critical care services and personnel: recommendations based on a system of categorization into two levels of care. American College of Critical Care Medicine of the Society of Critical Care Medicine.重症监护服务与人员:基于两级护理分类系统的建议。危重病医学会美国重症监护医学学院
Crit Care Med. 1999 Feb;27(2):422-6.
4
Critical care pharmacy services in United States hospitals.美国医院的重症监护药学服务。
Ann Pharmacother. 2006 Apr;40(4):612-8. doi: 10.1345/aph.1G590. Epub 2006 Mar 28.
5
Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.药剂师参与重症监护病房对血栓栓塞或梗死相关事件的重症患者临床和经济结局的影响。
Pharmacotherapy. 2009 Jul;29(7):761-8. doi: 10.1592/phco.29.7.761.
6
National survey of critical-care pharmaceutical services.重症监护药学服务全国调查。
Am J Hosp Pharm. 1989 Nov;46(11):2308-12.
7
Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.政策与实践:医疗和教育环境中处方治疗与耐用医疗设备的比较
Pediatrics. 2004 Nov;114(5):e612-25. doi: 10.1542/peds.2004-1063.
8
Position Paper on Critical Care Pharmacy Services: 2020 Update.危重病药学服务立场文件:2020 年更新版。
Crit Care Med. 2020 Sep;48(9):e813-e834. doi: 10.1097/CCM.0000000000004437.
9
Guidelines for the transfer of critically ill patients. Guidelines Committee, American College of Critical Care Medicine, Society of Critical Care Medicine and the Transfer Guidelines Task Force.危重症患者转运指南。指南委员会,美国重症医学学会、危重症医学会及转运指南特别工作组。
Am J Crit Care. 1993 May;2(3):189-95.
10
Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update.危重病药学服务立场文件(执行摘要):2020 年更新。
Crit Care Med. 2020 Sep;48(9):1375-1382. doi: 10.1097/CCM.0000000000004438.

引用本文的文献

1
The roles and patterns of critical care pharmacists: a literature review and practical operation model in China.重症监护药师的角色与模式:一项文献综述及中国的实际操作模型
Front Pharmacol. 2024 Nov 6;15:1439145. doi: 10.3389/fphar.2024.1439145. eCollection 2024.
2
Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.巴勒斯坦医疗中心重症监护病房临床药师干预的成本效益分析:前瞻性干预研究。
Saudi Pharm J. 2022 Dec;30(12):1718-1724. doi: 10.1016/j.jsps.2022.09.017. Epub 2022 Oct 6.
3
Pharmacists Are Associated With Reduced Mortality in Critically Ill Patients: Now What?
药剂师与危重症患者死亡率降低相关:接下来该怎么做?
Crit Care Med. 2019 Dec;47(12):e1036-e1037. doi: 10.1097/CCM.0000000000003934.
4
Pharmacists' Roles in Critical Care: Environmental Scan of Current Practices in Canadian Intensive Care Units.药剂师在重症监护中的角色:加拿大重症监护病房当前实践的环境扫描
Can J Hosp Pharm. 2018 May-Jun;71(3):215-216. Epub 2018 Jun 28.
5
Knowledge and pharmaceutical care practice regarding inhaled therapy among registered and unregistered pharmacists: an urgent need for a patient-oriented health care educational program in Iraq.注册和未注册药剂师在吸入疗法方面的知识与药学服务实践:伊拉克迫切需要一个以患者为导向的医疗保健教育项目。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 12;13:879-888. doi: 10.2147/COPD.S157403. eCollection 2018.
6
Implementing the Use of Pharmacist Progress Notes in a Surgical ICU.在外科重症监护病房实施药剂师病程记录的应用
Hosp Pharm. 2016 Jul;51(7):577-84. doi: 10.1310/hpj5107-577.
7
Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.药剂师干预对重症监护病房药物治疗费用的影响。
Pharm Pract (Granada). 2009 Apr;7(2):81-7. doi: 10.4321/s1886-36552009000200003. Epub 2009 Mar 15.
8
Development of clinical pharmacy services for intensive care units in Korea.韩国重症监护病房临床药学服务的发展。
Springerplus. 2014 Jan 17;3:34. doi: 10.1186/2193-1801-3-34. eCollection 2014.
9
Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital.临床药师干预对某三级甲等教学医院重症监护病房药物治疗费用的影响。
J Pharmacol Pharmacother. 2012 Jul;3(3):242-7. doi: 10.4103/0976-500X.99422.
10
[Not Available].[无可用内容]。
Can J Hosp Pharm. 2010 Mar;63(2):119-29. doi: 10.4212/cjhp.v63i2.897.